These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25889106)

  • 1. HIV-1 diversity in an antiretroviral treatment naïve cohort from Bushbuckridge, Mpumalanga Province, South Africa.
    Msimanga PW; Vardas E; Engelbrecht S
    Virol J; 2015 Feb; 12():24. PubMed ID: 25889106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 subtypes B and C unique recombinant forms (URFs) and transmitted drug resistance identified in the Western Cape Province, South Africa.
    Jacobs GB; Wilkinson E; Isaacs S; Spies G; de Oliveira T; Seedat S; Engelbrecht S
    PLoS One; 2014; 9(6):e90845. PubMed ID: 24609015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of antiretroviral drug resistance mutations and HIV-I subtypes among newly-diagnosed drug-naïve persons visiting a voluntary testing and counselling centre in northeastern South Africa.
    Nwobegahay JM; Bessong PO; Masebe TM; Mavhandu LG; Iweriebor BC; Selabe G
    J Health Popul Nutr; 2011 Aug; 29(4):303-9. PubMed ID: 21957668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV type 1 diversity and antiretroviral drug resistance mutations in Burundi.
    Vidal N; Niyongabo T; Nduwimana J; Butel C; Ndayiragije A; Wakana J; Nduwimana M; Delaporte E; Peeters M
    AIDS Res Hum Retroviruses; 2007 Jan; 23(1):175-80. PubMed ID: 17263648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Genetics and the Incidence of Transmitted Drug Resistance Among Pre-Treatment HIV-1 Infected Patients in the Eastern Cape, South Africa.
    Digban TO; Iweriebor BC; Obi LC; Nwodo U; Okoh AI
    Curr HIV Res; 2019; 17(5):335-342. PubMed ID: 31584370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low prevalence of transmitted genetic drug resistance in a cohort of HIV infected naïve patients entering antiretroviral treatment programs at two sites in northern South Africa.
    Nwobegahay J; Selabe G; Ndjeka NO; Manhaeve C; Bessong PO
    J Med Virol; 2012 Dec; 84(12):1839-43. PubMed ID: 23080485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of partial pol and env sequences indicates a high prevalence of HIV type 1 recombinant strains circulating in Gabon.
    Pandrea I; Robertson DL; Onanga R; Gao F; Makuwa M; Ngari P; Bedjabaga I; Roques P; Simon F; Apetrei C
    AIDS Res Hum Retroviruses; 2002 Oct; 18(15):1103-16. PubMed ID: 12396449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic characterization of HIV-1 strains in Togo reveals a high genetic complexity and genotypic drug-resistance mutations in ARV naive patients.
    Yaotsè DA; Nicole V; Roch NF; Mireille PD; Eric D; Martine P
    Infect Genet Evol; 2009 Jul; 9(4):646-52. PubMed ID: 19460333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms in the HIV-1 gp41 env gene, natural resistance to enfuvirtide (T-20) and pol resistance among pregnant Brazilian women.
    Reis MN; de Alcântara KC; Cardoso LP; Stefani MM
    J Med Virol; 2014 Jan; 86(1):8-17. PubMed ID: 24037943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of new, emerging HIV-1 unique recombinant forms and drug resistant viruses circulating in Cameroon.
    Ragupathy V; Zhao J; Wood O; Tang S; Lee S; Nyambi P; Hewlett I
    Virol J; 2011 Apr; 8():185. PubMed ID: 21513545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naïve patients from Central West Brazil.
    Cardoso LP; Queiroz BB; Stefani MM
    J Clin Virol; 2009 Oct; 46(2):134-9. PubMed ID: 19682948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moderate Levels of Pre-Treatment HIV-1 Antiretroviral Drug Resistance Detected in the First South African National Survey.
    Steegen K; Carmona S; Bronze M; Papathanasopoulos MA; van Zyl G; Goedhals D; MacLeod W; Sanne I; Stevens WS
    PLoS One; 2016; 11(12):e0166305. PubMed ID: 27907009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characteristics of human immunodeficiency virus type 1 subtype C viruses from KwaZulu-Natal, South Africa: implications for vaccine and antiretroviral control strategies.
    Gordon M; De Oliveira T; Bishop K; Coovadia HM; Madurai L; Engelbrecht S; Janse van Rensburg E; Mosam A; Smith A; Cassol S
    J Virol; 2003 Feb; 77(4):2587-99. PubMed ID: 12551997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV type 1 subtype diversity and drug resistance among HIV type 1-infected Kenyan patients initiating antiretroviral therapy.
    Lihana RW; Khamadi SA; Lubano K; Lwembe R; Kiptoo MK; Lagat N; Kinyua JG; Okoth FA; Songok EM; Makokha EP; Ichimura H
    AIDS Res Hum Retroviruses; 2009 Dec; 25(12):1211-7. PubMed ID: 19954302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral drug resistance surveillance among drug-naive HIV-1-infected individuals in Gauteng Province, South Africa in 2002 and 2004.
    Pillay V; Ledwaba J; Hunt G; Rakgotho M; Singh B; Makubalo L; Bennett DE; Puren A; Morris L
    Antivir Ther; 2008; 13 Suppl 2():101-7. PubMed ID: 18575198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High HIV Type 1 prevalence and wide genetic diversity with dominance of recombinant strains but low level of antiretroviral drug-resistance mutations in untreated patients in northeast Gabon, Central Africa.
    Mintsa-Ndong A; Caron M; Plantier JC; Makuwa M; Le Hello S; Courgnaud V; Roques P; Kazanji M
    AIDS Res Hum Retroviruses; 2009 Apr; 25(4):411-8. PubMed ID: 19320567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of HIV-1 pol sequences from Panama: identification of phylogenetic clusters within subtype B and detection of antiretroviral drug resistance mutations.
    Ahumada-Ruiz S; Flores-Figueroa D; Toala-González I; Thomson MM
    Infect Genet Evol; 2009 Sep; 9(5):933-40. PubMed ID: 19559103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug Resistance Mutations in a Population Before Antiretroviral Therapy Initiation in Northern South Africa.
    Ogola B; Matume ND; Mavhandu-Ramarumo LG; Tebit DM; Bessong PO
    AIDS Res Hum Retroviruses; 2022 Mar; 38(3):248-256. PubMed ID: 34107774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular diversity of HIV-1 and surveillance of transmitted drug resistance variants among treatment Naïve patients, 5 years after active introduction of HAART in Kuala Lumpur, Malaysia.
    Ong LY; Razak SN; Lee YM; Sri La Sri Ponnampalavanar S; Syed Omar SF; Azwa RI; Tee KK; Kamarulzaman A
    J Med Virol; 2014 Jan; 86(1):38-44. PubMed ID: 24127302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequencing and phylogenetic analysis of near full-length HIV-1 subtypes A, B, G and unique recombinant AC and AD viral strains identified in South Africa.
    Wilkinson E; Holzmayer V; Jacobs GB; de Oliveira T; Brennan CA; Hackett J; van Rensburg EJ; Engelbrecht S
    AIDS Res Hum Retroviruses; 2015 Apr; 31(4):412-20. PubMed ID: 25492033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.